Cutler Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cutler Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,900	Closed	-$2K	–	5710
2017 Q4	$2K	Sell	11,900 -9,400	-44%	-$23.4K	﹤0.01%	4308
2017 Q3	$4K	Sell	21,300 -108,300	-84%	-$369K	﹤0.01%	4704
2017 Q2	$8K	Sell	129,600 -81,900	-39%	-$338K	﹤0.01%	4465
2017 Q1	$37K	Buy	211,500 +186,400	+743%	+$1.08M	﹤0.01%	2711
2016 Q4	$14K	Buy	25,100 +23,100	+1,155%	+$121K	﹤0.01%	3880
2016 Q3	$1K	Sell	2,000 -18,500	-90%	-$86.6K	﹤0.01%	6466
2016 Q2	$3K	Buy	+20,500	New	+$69.5K	﹤0.01%	5509
2016 Q1	–	Sell	-37,200	Closed	-$5K	–	7578
2015 Q4	$5K	Buy	+37,200	New	+$227K	﹤0.01%	4989

Cutler Group's SGYP Position: Q2 2019 in Review

Cutler Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 9,400 shares.

Cutler Group first reported a position in SGYP in Q4 2015 and held it in 14 quarters. The position peaked at $634K in Q1 2017. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

Cutler Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
Cutler Group sold 9,400 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
Cutler Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 14 quarters.
Cutler Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $634K in Q1 2017.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.